Loading...
P01.065 Tumor treating fields (TTFields) in combination with lomustine (CCNU) in the EF-14 phase 3 clinical study - a safety analysis
INTRODUCTION: TTFields are low intensity, intermediate frequency, alternating electric fields. The significant overall and progression-free survival benefit, shown in the EF-14 phase 3 study was seen in all patient-subgroups, independent of e.g. MGMT-promotor methylation-status or age. TTFields were...
Na minha lista:
| Udgivet i: | Neuro Oncol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6144046/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.107 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|